Sklerosis Multipel: Diagnosis dan Tatalaksana

Penulis

  • Jimmy Christianto Suryo RSU Permata Husada, Kabupaten Bantul, Daerah Istimewa Yogyakarta, Indonesia

DOI:

https://doi.org/10.55175/cdk.v48i8.111

Kata Kunci:

Neurodegeneratif, sklerosis multipel, tatalaksana

Abstrak

Sklerosis multipel adalah lesi multipel sistem saraf pusat akibat rusaknya selubung mielin yang membungkus akson. Penyakit ini termasuk penyakit neurodegeneratif bersifat progresif dan relaps, sering mengenai wanita dewasa muda, memerlukan penanganan komprehensif dan sistematis. Penyebab penyakit belum diketahui pasti, diduga berkaitan dengan faktor infeksi virus atau proses autoimun atau genetik. Manifestasi klinisnya bervariasi. Kriteria diagnosis terbaru didasarkan pada Kriteria McDonald tahun 2017. Tatalaksana mencegah relaps dan progresivitas menggunakan corticosteroid, imunosupresan, imunomodulator, plasmapheresis (pertukaran plasma), atau DMAMS (Disease-Modifying Agent for Multiple Sclerosis), atau stem cell therapy. Prognosis tergantung komplikasi, progresivitas penyakit, dan pilihan terapi.

Multiple sclerosis is multiple lesions of the central nervous system due to damage to the axons’ myelin sheaths. This neurodegenerative disease is progressive and relapsing, often affecting young adult women, requiring comprehensive and systematic management. It is thought to be related to viral infection factors or autoimmune or genetic processes. The clinical manifestations are not typical depending on the brain lesion and disease progression. The latest diagnosis criteria are based on the 2017 McDonald Criteria. Management are to prevent relapse and progression using corticosteroids, immunosuppressants, immunomodulators, plasmapharesis (plasma exchange), or DMAMS (Disease-Modifying Agent For Multiple Sclerosis), or stem cell therapy. Prognosis depends on the complications, disease progression, and appropriate treatment options.

Unduhan

Data unduhan belum tersedia.

Referensi

Dobson. R, Giovannoni. G. Multiple sclerosis-a review. Eur J Neurol. 2019;26:27-38.

Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, de Stefano N, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis:practical guidelines. Brain 2019;142:1858-75.

Geeta Shroff. A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells. US National Library of Medicine National Institutes of Health [Internet]. 2018;11:1-11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813951/

Gossman W, Ehsan M, Xixis KL. Multiple sclerosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2019.

Haiga Y, Hamama DA, Frida M. Laporan kasus: Dua kasus multipel sklerosis dengan tipe yang berbeda di RSUP M.Djamil, Padang. Neurona. 2016;33(3):194-200.

Jafar Y. Tatalaksana multiple sclerosis. CDK 2017;44(3):180-3.

Kurniawan M, SuharjantiI, PinzonRT. et al. Multipel sklerosis. Buku acuan panduan praktik klinis neurologi. Jakarta: Perdossi; 2016 .p. 206-10.

Lindsay KW, Bone I, Fuller G, Callander R. Multiple sclerosis. Neurology and neurosurgery illustrated. 5th ed. London: Churchill Livingstone; 2010 .p. 520-8.

Mattle H, Mumethaler M. Multiple sclerosis. Fundamentals of neurology, an illustrated guide. New York: Thieme; 2017 .p. 237-45.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, et al. Clinical guideline on the pharmacological treatment of people with multiple sclerosis. MS Journal. 2018;24(2):96-120.

Omerhoca S, Akkas SY, Icen NK. Multiple sclerosis: Diagnosis and differential diagnosis. Noro Psikiyatr Ars. 2018;55(Suppl 1):1-9.

Polman CH, Reingold SC, Banwell B, et al. Clinical guideline of multiple sclerosis in adults: Management. NICE Guidelines [Internet]. 2014. Available from: www.nice.org.uk/guidance/cg186.

Rizminardo F, Syaarief I, Lestari R, Handayani T. Multiple sklerosis pada anak. Jurnal kesehatan Andalas. 2018;7(4):76-82.

Simon RP, Aminoff MJ, Greenberg DA. Multiple sclerosis. A lange medical book of clinical neurology. 10th ed. USA: McGraw-Hill Education; 2015 .p. 235-9.

Thaera G, Wingerchuk DM. Therapies for multiple sclerosis in evidence-based neurology, management of neurological disorders. 2nd ed. Wiley Online Library; 2015.p. 389-404.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-73. doi:10.1016/s1474-4422(17)30470-2

Tsang BK, Mcdonell R. Focus neurology: Multiple sclerosis-Diagnosis, management and prognosis. Austral Fam Physician. 2011;40(12):948-54.

Diterbitkan

2021-08-02

Cara Mengutip

Suryo, J. C. (2021). Sklerosis Multipel: Diagnosis dan Tatalaksana. Cermin Dunia Kedokteran, 48(8), 296–303. https://doi.org/10.55175/cdk.v48i8.111